Insider Transaction Report for BeOne Medicines Ltd.

Wu Xiaobin, President and COO of BeOne Medicines Ltd., reported a sale of 1357 American Depositary Shares (ADS) on June 16, 2026. The sale was conducted under a mandatory tax withholding provision related to a restricted share unit award, with prices ranging from $266.4658 to $266.8575 per ADS. Following this transaction, Wu Xiaobin directly holds 12,365 ADS and indirectly holds 4,000 ADS through his wife. Additionally, he holds 1,290,520 Ordinary Shares directly. The restricted share unit award vests incrementally over four years from June 15, 2023, subject to continued service, with provisions for accelerated vesting under certain termination conditions.